Analyst Ratings for Turnstone Biologics (TSBX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/5/2025 | Piper Sandler | Joseph Catanzaro | Downgrade | Neutral (Overweight) |
0.40 (3.75) |
0.41 (0.36) |
-12.2% | Details |
| 11/15/2024 | BofA Securities | Charlie Yang | Downgrade | Underperform (Neutral) |
0.40 (0.05) |
0.53 (0.36) |
-32.08% | Details |
![]() |
||||||||


